243 related articles for article (PubMed ID: 25700323)
21. Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications.
Saini M; Dhiman R; Dada T; Tandon R; Vanathi M
Eye (Lond); 2015 Jun; 29(6):808-14. PubMed ID: 25857609
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren's Syndrome Dry Eye.
Kang MJ; Kim YH; Chou M; Hwang J; Cheon EJ; Lee HJ; Chung SH
Ocul Immunol Inflamm; 2020 Apr; 28(3):370-378. PubMed ID: 30986119
[No Abstract] [Full Text] [Related]
24. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
25. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients.
Aragona P; Di Stefano G; Ferreri F; Spinella R; Stilo A
Br J Ophthalmol; 2002 Aug; 86(8):879-84. PubMed ID: 12140209
[TBL] [Abstract][Full Text] [Related]
26. Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears.
Nättinen J; Jylhä A; Aapola U; Enríquez-de-Salamanca A; Pinto-Fraga J; López-Miguel A; González-García MJ; Stern ME; Calonge M; Zhou L; Nykter M; Uusitalo H; Beuerman R
Ocul Surf; 2018 Jan; 16(1):84-92. PubMed ID: 28918083
[TBL] [Abstract][Full Text] [Related]
27. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
28. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.
Mencucci R; Boccalini C; Caputo R; Favuzza E
J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128
[TBL] [Abstract][Full Text] [Related]
29. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
Kim M; Kim HS; Na KS
Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
[TBL] [Abstract][Full Text] [Related]
30. The effect of intense pulsed light combined with topical 0.05% cyclosporin an eyedrops in the treatment of Sjögren's syndrome related dry eye.
Huo Y; Huang X; Lin L; Yang S; Qin Z; Yirui Z; Mou Y; Jin X
Expert Rev Clin Immunol; 2024 May; ():1-7. PubMed ID: 38785065
[TBL] [Abstract][Full Text] [Related]
31. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
32. The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes.
Liu X; Wang S; Kao AA; Long Q
Cornea; 2012 Nov; 31(11):1235-9. PubMed ID: 22677643
[TBL] [Abstract][Full Text] [Related]
33. Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren's syndrome versus non-Sjogren's syndrome.
Cubuk MO; Ucgul AY; Ozgur A; Ozulken K; Yuksel E
Int Ophthalmol; 2021 Apr; 41(4):1479-1485. PubMed ID: 33484384
[TBL] [Abstract][Full Text] [Related]
34. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
[TBL] [Abstract][Full Text] [Related]
35. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
Arimoto A; Kitagawa K; Mita N; Takahashi Y; Shibuya E; Sasaki H
Cornea; 2014 Aug; 33(8):806-11. PubMed ID: 24977983
[TBL] [Abstract][Full Text] [Related]
36. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Clinical Efficacy and Safety of a Novel Cyclosporin A Nanoemulsion in the Treatment of Dry Eye Syndrome.
Kim HS; Kim TI; Kim JH; Yoon KC; Hyon JY; Shin KU; Choi CY
J Ocul Pharmacol Ther; 2017 Sep; 33(7):530-538. PubMed ID: 28759302
[TBL] [Abstract][Full Text] [Related]
38. Serologic Markers Are Associated With Ocular Staining Score in Primary Sjögren Syndrome.
Lim SA; Nam S; Kwok SK; Park SH; Chung SH
Cornea; 2015 Nov; 34(11):1466-70. PubMed ID: 26356755
[TBL] [Abstract][Full Text] [Related]
39. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
[TBL] [Abstract][Full Text] [Related]
40. A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease.
Abud TB; Amparo F; Saboo US; Di Zazzo A; Dohlman TH; Ciolino JB; Hamrah P; Dana R
Ophthalmology; 2016 Jul; 123(7):1449-57. PubMed ID: 27086024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
